Immune Therapeutics Signs Distribution MOU for Lodonal in Kenya; Company Plans to Open Kenya for Lodonal in 2017
Publish date unknown
ORLANDO, FL / ACCESSWIRE / March 8, 2017 / Immune Therapeutics, Inc. (OTCQB: IMUN), a clinical-stage pharmaceutical company developing novel, non-toxic affordable therapies to treat ...
Concept cloud